U.S. Army To Move Ahead With Exclusive Licensing Of Experimental Zika Vaccine To Sanofi Pasteur
STAT: Army rejects request to deny Sanofi an exclusive license for a Zika vaccine
“The U.S. Army is proceeding with plans to grant Sanofi Pasteur an exclusive license to develop a vaccine for the Zika virus, despite concerns among some lawmakers and advocacy groups that the product may be priced too high for many Americans, even though it was developed with taxpayer funds…” (Silverman, 4/24).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.